Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.09M Sell
11,300
-183,400
-94% -$62.8M 0.01% 941
2026
Q1
$68.5M Sell
194,700
-115,700
-37% -$41.2M 0.16% 121
2025
Q4
$102M Buy
310,400
+305,000
+5,648% +$96.7M 0.19% 94
2025
Q3
$1.52M Sell
5,400
-91,300
-94% -$26.5M ﹤0.01% 1649
2025
Q2
$27M Sell
96,700
-66,300
-41% -$18.8M 0.05% 311
2025
Q1
$50.8M Buy
163,000
+41,900
+35% +$12.4M 0.11% 139
2024
Q4
$31.6M Buy
+121,100
New +$35.9M 0.07% 251

Other funds holding AMGN

PEAK6's AMGN Position: Q2 2026 in Review

PEAK6 held its Amgen (AMGN) position steady in Q2 2026 at 2 shares worth $631. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

PEAK6 first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.02M in Q2 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PEAK6 held 2 shares of Amgen worth $631 as of Q2 2026.
  • PEAK6 left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2624 holding.
  • PEAK6 first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • PEAK6's Amgen position peaked at $4.02M in Q2 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.